Panic attacks in Seebri - how severe and when it was recovered? (a real world drug study)

Summary:

We study how severe was Panic attacks, when it was recovered, drug effectiveness, race, and more among people who take Seebri (glycopyrrolate). This phase IV clinical study is created by eHealthMe based on reports submitted to eHealthMe, and is updated regularly.

What is Seebri?

Seebri has active ingredients of glycopyrrolate. eHealthMe is studying from 2,618 Seebri users. Check the latest studies of Seebri.

What is Panic attacks?

Panic attacks is found to be associated with 2,079 drugs and 2,076 conditions by eHealthMe. Check the latest studies of Panic attacks.

On Jun, 28, 2026

1 person who has Panic attacks while taking Seebri was studied.

Severity of Panic attacks:

n/a

When people recovered from Panic attacks:

n/a

How effective is Seebri:

n/a

Race of the people *:

African American, Non-Hispanic: 0.0 %
American Indian/Alaska Native: 0.0 %
Asian: 0.0 %
Hispanic: 0.0 %
Native Hawaiians/Pacific Islanders: 0.0 %
Two or more races: 0.0 %
White, Non-Hispanic: 100 %

Gender of people when taking Seebri *:

female: 100 %
male: 0.0 %

Age of people when taking Seebri *:

Conditions people have *:

Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 1 person, 100.00%

Other drugs people take besides Seebri *:

Ventolin: 1 person, 100.00%

Other side effects people have besides Panic attacks *:

Stress And Anxiety: 1 person, 100.00%
Headache (pain in head): 1 person, 100.00%
Fatigue (feeling of tiredness): 1 person, 100.00%
Depression: 1 person, 100.00%
Chills (felling of cold): 1 person, 100.00%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Seebri and have Panic attacks?

Check whether Panic attacks is associated with a drug or a condition

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Related studies

Panic attacks in Seebri

How the study uses the data?

The study is based on glycopyrrolate (the active ingredients of Seebri). Other drugs that have the same active ingredients (e.g. generic drugs) are considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.